UBS Group AG - NEXIMMUNE INC ownership

NEXIMMUNE INC's ticker is NEXI and the CUSIP is 65344D109. A total of 47 filers reported holding NEXIMMUNE INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of NEXIMMUNE INC
ValueSharesWeighting
Q3 2023$10
-28.6%
490.0%0.00%
Q2 2023$14
-26.3%
490.0%0.00%
Q1 2023$19
-99.5%
49
-99.7%
0.00%
Q4 2022$3,990
-50.1%
16,622
+13.7%
0.00%
Q3 2022$8,000
+100.0%
14,624
+473.7%
0.00%
Q2 2022$4,000
-20.0%
2,549
+106.1%
0.00%
Q1 2022$5,000
-80.8%
1,237
-78.2%
0.00%
Q4 2021$26,000
+44.4%
5,674
+425.4%
0.00%
Q2 2021$18,000
-50.0%
1,080
-42.6%
0.00%
Q1 2021$36,0001,8830.00%
Other shareholders
NEXIMMUNE INC shareholders Q2 2022
NameSharesValueWeighting ↓
ALLEN OPERATIONS LLC 635,934$10,378,0001.78%
Slate Path Capital LP 925,000$15,096,0000.84%
BRIDGER MANAGEMENT, LLC 400,000$6,528,0000.61%
Artal Group S.A. 1,200,000$19,584,0000.40%
DSAM Partners (London) Ltd 89,500$1,461,0000.24%
SUVRETTA CAPITAL MANAGEMENT, LLC 365,762$5,969,0000.09%
TimesSquare Capital Management, LLC 482,100$7,868,0000.06%
Johns Hopkins University 26,919$439,0000.05%
683 Capital Management, LLC 60,000$979,0000.03%
ADAGE CAPITAL PARTNERS GP, L.L.C. 704,371$11,495,0000.02%
View complete list of NEXIMMUNE INC shareholders